dioscin has been researched along with dimethylnitrosamine in 2 studies
| Studies (dioscin) | Trials (dioscin) | Recent Studies (post-2010) (dioscin) | Studies (dimethylnitrosamine) | Trials (dimethylnitrosamine) | Recent Studies (post-2010) (dimethylnitrosamine) |
|---|---|---|---|---|---|
| 250 | 0 | 200 | 2,874 | 6 | 498 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, L; Han, X; Peng, J; Qi, Y; Tao, X; Xu, L; Xu, Y; Yin, L | 1 |
| Han, X; Peng, J; Tao, X; Wang, C; Xu, L; Xu, Y; Yin, L; Zhang, W; Zheng, L | 1 |
2 other study(ies) available for dioscin and dimethylnitrosamine
| Article | Year |
|---|---|
Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated inhibition of p38 MAPK pathway.
Topics: Animals; Bile Ducts; Dimethylnitrosamine; Diosgenin; Dose-Response Relationship, Drug; Hepatic Stellate Cells; Humans; Ligation; Liver Cirrhosis; Male; MAP Kinase Signaling System; NF-E2-Related Factor 2; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sirtuin 1 | 2016 |
Dioscin alleviates dimethylnitrosamine-induced acute liver injury through regulating apoptosis, oxidative stress and inflammation.
Topics: Animals; Apoptosis; Chemical and Drug Induced Liver Injury; Cytokines; Dimethylnitrosamine; Dioscorea; Diosgenin; Interferon-Stimulated Gene Factor 3, gamma Subunit; Male; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; NF-E2-Related Factor 2; Oxidative Stress; Rats, Sprague-Dawley; Signal Transduction; Sirtuin 1; Toll-Like Receptor 4 | 2016 |